Bruce C. Cozadd
2007
In 2007, Bruce C. Cozadd earned a total compensation of $1.1M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $115,000 |
|---|---|
| Option Awards | $651,599 |
| Salary | $355,273 |
| Other | $521 |
| Total | $1,122,393 |
Cozadd received $651.6K in option awards, accounting for 58% of the total pay in 2007.
Cozadd also received $115K in non-equity incentive plan, $355.3K in salary and $521 in other compensation.
Rankings
In 2007, Bruce C. Cozadd's compensation ranked 3,773rd out of 8,700 executives tracked by ExecPay. In other words, Cozadd earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,773 out of 8,700 | 57th |
Division Manufacturing | 1,348 out of 3,314 | 59th |
Major group Chemicals And Allied Products | 259 out of 746 | 65th |
Industry group Drugs | 146 out of 546 | 73rd |
Industry Pharmaceutical Preparations | 108 out of 364 | 70th |
Source: SEC filing on October 23, 2009.
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2007.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019